Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - betamethasone valerate eqv betamethasone - cream - 0.1% w/w - betamethasone valerate eqv betamethasone 0.1% w/w

Singapore - English - HSA (Health Sciences Authority)

somnotec (s) pte. ltd. - ear, nose & throat - stent for use in the trachea or bronchus. the product is used to keep the airway open. the product is for long-term use (application duration > 29 days). indications: *tracheobronchial tumors *tracheobronchial stenoses with scarring *tracheobronchial stenoses after anastomosis, resection or lung transplantation *diameter reduction from intraluminal, extraluminal and intramural changes

Singapore - English - HSA (Health Sciences Authority)

somnotec (s) pte. ltd. - general & plastic surgery - for maintaining open the airways, after dilatation of the stenosis or resection of the obstruction, in particular in case of: - tracheo-bronchial tumors - tracheal stenoses with scarring - stenoses following anastomosis, surgical treatment or pulmonary transplantation - in general after any diminuation of the diameter by inner or outer compression

Singapore - English - HSA (Health Sciences Authority)

somnotec (s) pte. ltd. - general & plastic surgery - for maintaining open the airways, after dilatation of the stenosis or resection of the obstruction, in particular in case of: - tracheo-bronchial tumors - tracheal stenoses with scarring - stenoses following anastomosis, surgical treatment or pulmonary transplantation - in general after any diminuation of the diameter by inner or outer compression

Singapore - English - HSA (Health Sciences Authority)

all eights (singapore) private limited - immunology - the novatec varicella-zoster virus (vzv) igg-elisa is intended for the qualitative determination of igg class antibodies against varicella-zoster virus in human serum or plasma (citrate).

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - betamethasone valerate 0.1%{relative} (0.122% with overage); clioquinol 3%{relative} - topical ointment - active: betamethasone valerate 0.1%{relative} (0.122% with overage) clioquinol 3%{relative} excipient: liquid paraffin white soft paraffin - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 1.21 mg/g (equivalent: betamethasone, qty 1 mg/g) - cream - excipient ingredients: purified water; white soft paraffin; liquid paraffin; chlorocresol; cetostearyl alcohol; cetomacrogol 1000; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - betamethasone as valerate - cream - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - betamethasone as valerate - ointment - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.these include the following:atopic dermatitis (including infantile atopic dermatitis)nummular dermatitis (discoid eczema)prurigo nodularispsoriasis (excluding widespread plaque psoriasis)lichen simplex chronicus (neurodermatitis) and lichen planusseborrhoeic dermatitisirritant or allergic contact dermatitisdiscoid lupus erythematosusadjunct to systemic steroid therapy in generalised erythroderma

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - betamethasone - cream - 0.1 percent weight/weight - corticosteroids, potent (group iii); betamethasone